BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 27, 2011
View Archived Issues
LIPN gene mutation correlates with late-onset autosomal recessive ichthyosis
Read More
HRA Pharma and ASKA Pharmaceutical enter licensing agreement in Japan for ellaOne
Read More
Novel phosphodiesterase 10A inhibitors designed
Read More
New sponge-derived anticancer polyketides described
Read More
Daiichi Sankyo presents novel erythropoietin production enhancers
Read More
InterMune provides update on development and commercialization of Esbriet
Read More
Oncothyreon begins phase II portion of phase I/II trial of PX-866 with cetuximab
Read More
Initiation of phase II study triggers milestone payment from Bristol-Myers Squibb to AMRI
Read More
Preclinical data support further development of PF-4348235 for treatment of COPD
Read More
Findings disclosed from two phase II trials of NXL-104/ceftazidime
Read More
Nexvax-2 vaccine is safe and bioactive in phase I trial in celiac disease
Read More
Centella Therapeutics gains exclusive rights to antitumor agent CEN-209
Read More
FDA approves IND for phase I trial of PWT-33597
Read More
Aastrom and CPC Clinical Research enter agreement for phase III REVIVE program of ixmyelocel-T
Read More
FLAME study shows enhanced stroke recovery with fluoxetine
Read More
Dynavax completes 12-month follow-up in phase III Heplisav trial
Read More
Active Biotech's ABR-215757 improves SLE symptoms in exploratory phase II trial
Read More
GSK presents new bromodomain inhibitors
Read More
Phase II extension data encouraging for Derma Sciences' DSC-127 in diabetes-related foot ulcers
Read More
EV-71 vaccine against hand, foot and mouth disease shows promise in phase I trial
Read More
Futurechem presents new beta-amyloid production inhibitors
Read More
Lytix Biopharma completes two phase I/IIa trials of topical antimicrobial drug Lytixar
Read More
NHLBI stops AIM-HIGH study of niacin added to simvastatin early
Read More
Ellavie spray approved in Sweden to treat symptoms of menopause
Read More
Zeria presents data showing efficacy of Acofide in treatment of functional dyspepsia
Read More
German authorities approve Sativex for treatment of spasticity due to MS
Read More